Changzhou Qianhong BiopharmaLTD Balance Sheet Health
Financial Health criteria checks 6/6
Changzhou Qianhong BiopharmaLTD has a total shareholder equity of CN¥2.5B and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 0.8%. Its total assets and total liabilities are CN¥2.8B and CN¥277.4M respectively. Changzhou Qianhong BiopharmaLTD's EBIT is CN¥310.0M making its interest coverage ratio -20.8. It has cash and short-term investments of CN¥708.5M.
Key information
0.8%
Debt to equity ratio
CN¥20.02m
Debt
| Interest coverage ratio | -20.8x |
| Cash | CN¥708.52m |
| Equity | CN¥2.48b |
| Total liabilities | CN¥277.37m |
| Total assets | CN¥2.76b |
Recent financial health updates
Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly
Aug 21
Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?
Mar 24Recent updates
Do Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Warrant Your Attention?
Nov 18Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 21Here's Why Changzhou Qianhong BiopharmaLTD (SZSE:002550) Can Manage Its Debt Responsibly
Aug 21Changzhou Qianhong BiopharmaLTD (SZSE:002550) Has Affirmed Its Dividend Of CN¥0.12
May 26Changzhou Qianhong Biopharma CO.,LTD (SZSE:002550) Looks Just Right With A 26% Price Jump
May 21Investors Can Find Comfort In Changzhou Qianhong BiopharmaLTD's (SZSE:002550) Earnings Quality
May 02Does Changzhou Qianhong BiopharmaLTD (SZSE:002550) Have A Healthy Balance Sheet?
Mar 24Financial Position Analysis
Short Term Liabilities: 002550's short term assets (CN¥1.5B) exceed its short term liabilities (CN¥185.0M).
Long Term Liabilities: 002550's short term assets (CN¥1.5B) exceed its long term liabilities (CN¥92.4M).
Debt to Equity History and Analysis
Debt Level: 002550 has more cash than its total debt.
Reducing Debt: 002550's debt to equity ratio has reduced from 23.8% to 0.8% over the past 5 years.
Debt Coverage: 002550's debt is well covered by operating cash flow (2962.4%).
Interest Coverage: 002550 earns more interest than it pays, so coverage of interest payments is not a concern.